Related references
Note: Only part of the references are listed.Determination of benzimidazole- and bicyclic hydantoin-derived selective androgen receptor antagonists and agonists in human urine using LC-MS/MS
Mario Thevis et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2008)
Current role of LC-MS(/MS) in doping control
Mario Thevis et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2007)
Doping-control analysis of the 5α-reductase inhibitor finasteride:: Determination of its influence on urinary steroid profiles and detection of its major urinary metabolite
Mario Thevis et al.
THERAPEUTIC DRUG MONITORING (2007)
Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinones
Arjan van Oeveren et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis
Mario Thevis et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2007)
Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids
Costas G. Georgakopoulos et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2007)
Mass spectrometry in sports drug testing: Structure characterization and analytical assays
Mario Thevis et al.
MASS SPECTROMETRY REVIEWS (2007)
Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)
Wenqing Gao et al.
DRUG DISCOVERY TODAY (2007)
Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffold
Chongqing Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Discovery of 6-N,N-bis(2,2,2-trifluoroethyl)amino-4-trifluoromethylquinolin-2(1H)-one as a novel selective androgen receptor modulator
Arjan van Oeveren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands
Wenqing Gao et al.
PHARMACEUTICAL RESEARCH (2006)
Drug Insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging
S Bhasin et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2006)
Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification
MWF Nielen et al.
ANALYTICAL CHEMISTRY (2006)
Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes
M Thevis et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2006)
Nonsteroidal tissue selective androgen receptor modulators: a promising class of clinical candidates
ML Mohler et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2005)
Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry
M Thevis et al.
JOURNAL OF MASS SPECTROMETRY (2005)
Mass Spectrometry in doping control analysis
M Thevis et al.
CURRENT ORGANIC CHEMISTRY (2005)
A selective androgen receptor modulator for hormonal male contraception
JY Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Another designer steroid: discovery, synthesis, and detection of 'madol' in urine
MH Sekera et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2005)
Androgen replacement therapy - Present and future
LJG Gooren et al.
DRUGS (2004)
Tetrahydrogestrinone: discovery, synthesis, and detection in urine
DH Catlin et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2004)
Progress towards hormonal male contraception
A Kamischke et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Anabolic steroids in sport: biochemical, clinical and analytical perspectives
AT Kicman et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2003)
Detection of norbolethone, an anabolic steroid never marketed, in athletes' urine
DH Catlin et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2002)
Share Paper
